Josefa Diez-Zaldivar
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Quantitative Analysis of Locus Coeruleus Neurons and Thalamic Noradrenergic Axons in a Progressive 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Monkey Model of Parkinson's Disease.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: December 23, 2025
Cortical Type: The Basis for a Modern Neurodevelopmental Synthesis (Ontogeny, Phylogeny, Synaptic Connectivity) of the Human Cerebral Cortex.
Journal: The Journal of comparative neurology
Published: September 17, 2025
Recovery of the full in vivo firing range in post-lesion surviving DA SN neurons associated with Kv4.3-mediated pacemaker plasticity.
Journal: eLife
Published: October 16, 2024
Cognitive enhancement, TAU phosphorylation reduction, and neuronal protection by the treatment of an LRRK2 inhibitor in a tauopathy mouse model.
Journal: Neurobiology of aging
Published: February 25, 2020
Benzothiazole-Based LRRK2 Inhibitors as Wnt Enhancers and Promoters of Oligodendrocytic Fate.
Journal: Journal of medicinal chemistry
Published: December 12, 2019
Discovery of novel Schistosoma mansoni PDE4A inhibitors as potential agents against schistosomiasis.
Discovery of novel Schistosoma mansoni PDE4A inhibitors as potential agents against schistosomiasis.
Journal: Future medicinal chemistry
Published: August 03, 2019
Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors.
Journal: Journal of medicinal chemistry
Published: August 07, 2018
Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa.
Journal: Molecular neurodegeneration
Published: June 15, 2017
Correction to "Classics in Chemical Neuroscience: Haloperidol".
Journal: ACS chemical neuroscience
Published: May 17, 2017
Leucine rich repeat kinase 2 (LRRK2) inhibitors based on indolinone scaffold: Potential pro-neurogenic agents.
Journal: European journal of medicinal chemistry
Published: May 04, 2017
Classics in Chemical Neuroscience: Haloperidol.
Journal: ACS chemical neuroscience
Published: February 08, 2017
Small molecules targeting glycogen synthase kinase 3 as potential drug candidates for the treatment of retinitis pigmentosa.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: January 25, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026